Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pedersen

Showing results (1251-1260 of 1,408) with videos related to

Pageof 141
Sort By:
BMC Cancer|May 20, 2025
Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ductal adenocarcinomaRasmus S Pedersen, Annika Hettich, Jeppe Thorlacius-Ussing, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 23, 2013
Health-related quality of life in the elderly three years after percutaneous coronary interventionAnna Panasewicz, Susanne S Pedersen, Stefanie J G Veenhuis, et al.
European Journal of Haematology|December 30, 2015
Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort studyRasmus Sørrig, Tobias W Klausen, Morten Salomo, et al.
Cost Effectiveness and Resource Allocation : C/E|April 13, 2024
Health economic evaluation of blended collaborative care for older multimorbid heart failure patients: study protocolLisa Derendorf, Stephanie Stock, Dusan Simic, et al.
The Pharmacogenomics Journal|April 7, 2010
Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancerT K Bergmann, C Brasch-Andersen, H Gréen, et al.
Acta Oncologica (Stockholm, Sweden)|November 23, 2017
Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCGI M H Soenderstrup, A V Laenkholm, M B Jensen, et al.
The Oncologist|November 25, 2022
Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic AdenocarcinomaPatrick M Grierson, Benjamin Tan, Katrina S Pedersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2021
ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel AdenocarcinomaKatrina S Pedersen, Nathan R Foster, Michael J Overman, et al.
Reproductive Toxicology (Elmsford, N.Y.)|August 2, 2014
Interactions between polymorphisms in the aryl hydrocarbon receptor signalling pathway and exposure to persistent organochlorine pollutants affect human semen qualityL J S Brokken, P J Lundberg, M Spanò, et al.
Journal of Psychosomatic Research|October 15, 2005
Feelings of being disabled as a risk factor for mortality up to 8 years after acute myocardial infarctionMaureen J van der Vlugt, Ron T van Domburg, Susanne S Pedersen, et al.
Pageof 141

Showing results (1251-1260 of 1,408) with videos related to

Sort By:
Pageof 141
BMC Cancer|May 20, 2025
Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ductal adenocarcinomaRasmus S Pedersen, Annika Hettich, Jeppe Thorlacius-Ussing, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 23, 2013
Health-related quality of life in the elderly three years after percutaneous coronary interventionAnna Panasewicz, Susanne S Pedersen, Stefanie J G Veenhuis, et al.
European Journal of Haematology|December 30, 2015
Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort studyRasmus Sørrig, Tobias W Klausen, Morten Salomo, et al.
Cost Effectiveness and Resource Allocation : C/E|April 13, 2024
Health economic evaluation of blended collaborative care for older multimorbid heart failure patients: study protocolLisa Derendorf, Stephanie Stock, Dusan Simic, et al.
The Pharmacogenomics Journal|April 7, 2010
Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancerT K Bergmann, C Brasch-Andersen, H Gréen, et al.
Acta Oncologica (Stockholm, Sweden)|November 23, 2017
Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCGI M H Soenderstrup, A V Laenkholm, M B Jensen, et al.
The Oncologist|November 25, 2022
Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic AdenocarcinomaPatrick M Grierson, Benjamin Tan, Katrina S Pedersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2021
ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel AdenocarcinomaKatrina S Pedersen, Nathan R Foster, Michael J Overman, et al.
Reproductive Toxicology (Elmsford, N.Y.)|August 2, 2014
Interactions between polymorphisms in the aryl hydrocarbon receptor signalling pathway and exposure to persistent organochlorine pollutants affect human semen qualityL J S Brokken, P J Lundberg, M Spanò, et al.
Journal of Psychosomatic Research|October 15, 2005
Feelings of being disabled as a risk factor for mortality up to 8 years after acute myocardial infarctionMaureen J van der Vlugt, Ron T van Domburg, Susanne S Pedersen, et al.
Pageof 141